Discover B2B leads for Health Diagnostics industry
Identify and research relevant prospects for B2B lead generation on Health Diagnostics sector. Find their verified contact details to reach out to them, nurture and convert them into paying clients. Streamline the process of filtering B2B prospects by searching for bisinesses based on their specifics like location, name or category.
Businesses
Found 2 in our database
Found 21 in our records
HQ: Cambridge, Cambridgeshire, United Kingdom
Horizon Discovery
Horizon is a gene editing company that designs & eShow more...ngineers genetically-modified cells, applying them to advance human health.
HQ: Cambridge, Cambridgeshire, United Kingdom
Specialized In: Pharmaceuticals, Biotechnology, Health Diagnostics
Business Type: Public
Employees: 101-250
Rounds: Post-IPO Equity
Last Investment Activity: Feb 10, 2022
Founded Date: Jun 2007
Company Type: For Profit
Stock Symbol: LSE:HZD
Operating Status: Active
10 Emails
0 Phones
Main email format: sarah.smith@horizondiscovery.com (100.0%)
-
Kevin Koker
Customer Service Manager
k*********r@horizondiscovery.com
-
Jon Aviles
General Manager
j********s@horizondiscovery.com
-
Natalie Cowan
Business Development Manager
n***********n@horizondiscovery.com
-
Jon Nunez
Vice President , Finance
j*******z@horizondiscovery.com
-
Jeffrey Dale
Business Development Manager, Midwest (South), Products and Services (including In Vivo)
j**********e@horizondiscovery.com
-
Abhay Joshi
Business Development Manager
a*********i@horizondiscovery.com
-
Hadas Raveh-Amit
Senior Scientist
h*************t@horizondiscovery.com
-
General Inquiries
info@horizondiscovery.com
-
Sales Department
sales@horizondiscovery.com
-
Legal Department
legal@horizondiscovery.com
HQ: Wadenswil, Zurich, Switzerland
Numab
Numab is a biotechnology company that offers antibShow more...ody-based therapeutics for the treatment of severe diseases.
HQ: Wadenswil, Zurich, Switzerland
Specialized In: Pharmaceuticals, Biotechnology, Healthcare & Medical, Health Diagnostics, Hospitals & Clinics
Business Type: Private
Employees: 51-100
Rounds: Series C
Last Investment Activity: Feb 13, 2024
Founded Date: 2011
Number of Exits: 1
Company Type: For Profit
Operating Status: Active
4 Emails
1 Phones
Main email format: s.smith@numab.com (100.0%)
-
David Urech
CSO, and Co-CEO, Founder
d*****h@numab.com
T***********************************************************************************m
-
Oliver Middendorp
CBO, Co-CEO, and Co-Founder
-
Peter Lichtlen
CMO and Co-Founder
-
Tea Gunde
Head of Pharmacology
-
Sebastian Meyer
Chief Operating Officer
-
Roland Helfenstein
Chief Financial Officer
-
General Inquiries
info@numab.com
-
Admin Team
admin@numab.com
-
Legal Department
legal@numab.com
- «
- 1
- »
We’re in beta testing! Sign up for free to unlock all the information on this page — no credit card required.